FDA Approved: VYONDYS 53 — Original Application (Sarepta Therapeutics, Inc.)

View source ↗

Summary

The FDA approved Sarepta Therapeutics' golodirsen (VYONDYS 53) as the original application for treatment of Duchenne muscular dystrophy due to mutations amenabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• VYONDYS 53 (golodirsen)

Snippet

ORIG AP for VYONDYS 53 (GOLODIRSEN)